Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma

Koichi Nishijo, Qing Rong Chen, Lei Zhang, Amanda T. McCleish, Andrea Rodriguez, Min Jung Cho, Suresh I. Prajapati, Jonathan A.L. Gelfond, Gary B. Chisholm, Joel E. Michalek, Bruce J. Aronow, Frederic G. Barr, R Randall, Marc Ladanyi, Stephen J. Qualman, Brian P. Rubin, Robin D. LeGaIIo, Chiayeng Wang, Javed Khan, Charles Keller

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The highly aggressive muscle cancer alveolar rhabdomyosar- coma (ABMS) is one of the most common soft tissue sarcoma of childhood, yet the outcome for the unresectable and metastatic disease is dismal and unchanged for nearly three decades. To better understand the pathogenesis of this disease and to facilitate novel preclinical approaches, we previously developed a conditional mouse model of ARMS by faithfully recapitulating the genetic mutations observed in the human disease, i.e., activation of Pax3:Fkhr fusion gene with either p53 or Cdkn2a inactivation. In this report, we show that this model recapitulates the immunohistochemical profile and the rapid progression of the human disease. We show that Pax3:Fkhr expression increases during late preneoplasia but tumor cells undergoing metastasis are under apparent selection for Pax3:Fkhr expression. At a whole-genome level, a cross-species gene set enrichment analysis and metagene projection study showed that our mouse model is most similar to human ARMS when compared with other pediatric cancers. We have defined an expression profile conserved between mouse and human ARMS, as well as a Pax&Fkhr signature, including the target gene, SKP2. We further identified 7 "draggable" kinases overexpressed across species. The data affirm the accuracy of this genetically engineered mouse model.

Original languageEnglish (US)
Pages (from-to)2902-2911
Number of pages10
JournalCancer Research
Volume69
Issue number7
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Alveolar Rhabdomyosarcoma
Credentialing
Muscle Neoplasms
Gene Fusion
Sarcoma
Genes
Disease Progression
Neoplasms
Phosphotransferases
Genome
Pediatrics
Neoplasm Metastasis
Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Nishijo, K., Chen, Q. R., Zhang, L., McCleish, A. T., Rodriguez, A., Cho, M. J., ... Keller, C. (2009). Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Research, 69(7), 2902-2911. https://doi.org/10.1158/0008-5472.CAN-08-3723

Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. / Nishijo, Koichi; Chen, Qing Rong; Zhang, Lei; McCleish, Amanda T.; Rodriguez, Andrea; Cho, Min Jung; Prajapati, Suresh I.; Gelfond, Jonathan A.L.; Chisholm, Gary B.; Michalek, Joel E.; Aronow, Bruce J.; Barr, Frederic G.; Randall, R; Ladanyi, Marc; Qualman, Stephen J.; Rubin, Brian P.; LeGaIIo, Robin D.; Wang, Chiayeng; Khan, Javed; Keller, Charles.

In: Cancer Research, Vol. 69, No. 7, 01.04.2009, p. 2902-2911.

Research output: Contribution to journalArticle

Nishijo, K, Chen, QR, Zhang, L, McCleish, AT, Rodriguez, A, Cho, MJ, Prajapati, SI, Gelfond, JAL, Chisholm, GB, Michalek, JE, Aronow, BJ, Barr, FG, Randall, R, Ladanyi, M, Qualman, SJ, Rubin, BP, LeGaIIo, RD, Wang, C, Khan, J & Keller, C 2009, 'Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma', Cancer Research, vol. 69, no. 7, pp. 2902-2911. https://doi.org/10.1158/0008-5472.CAN-08-3723
Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ et al. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Research. 2009 Apr 1;69(7):2902-2911. https://doi.org/10.1158/0008-5472.CAN-08-3723
Nishijo, Koichi ; Chen, Qing Rong ; Zhang, Lei ; McCleish, Amanda T. ; Rodriguez, Andrea ; Cho, Min Jung ; Prajapati, Suresh I. ; Gelfond, Jonathan A.L. ; Chisholm, Gary B. ; Michalek, Joel E. ; Aronow, Bruce J. ; Barr, Frederic G. ; Randall, R ; Ladanyi, Marc ; Qualman, Stephen J. ; Rubin, Brian P. ; LeGaIIo, Robin D. ; Wang, Chiayeng ; Khan, Javed ; Keller, Charles. / Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. In: Cancer Research. 2009 ; Vol. 69, No. 7. pp. 2902-2911.
@article{f2686e800eeb40c9b620e812c36df180,
title = "Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma",
abstract = "The highly aggressive muscle cancer alveolar rhabdomyosar- coma (ABMS) is one of the most common soft tissue sarcoma of childhood, yet the outcome for the unresectable and metastatic disease is dismal and unchanged for nearly three decades. To better understand the pathogenesis of this disease and to facilitate novel preclinical approaches, we previously developed a conditional mouse model of ARMS by faithfully recapitulating the genetic mutations observed in the human disease, i.e., activation of Pax3:Fkhr fusion gene with either p53 or Cdkn2a inactivation. In this report, we show that this model recapitulates the immunohistochemical profile and the rapid progression of the human disease. We show that Pax3:Fkhr expression increases during late preneoplasia but tumor cells undergoing metastasis are under apparent selection for Pax3:Fkhr expression. At a whole-genome level, a cross-species gene set enrichment analysis and metagene projection study showed that our mouse model is most similar to human ARMS when compared with other pediatric cancers. We have defined an expression profile conserved between mouse and human ARMS, as well as a Pax&Fkhr signature, including the target gene, SKP2. We further identified 7 {"}draggable{"} kinases overexpressed across species. The data affirm the accuracy of this genetically engineered mouse model.",
author = "Koichi Nishijo and Chen, {Qing Rong} and Lei Zhang and McCleish, {Amanda T.} and Andrea Rodriguez and Cho, {Min Jung} and Prajapati, {Suresh I.} and Gelfond, {Jonathan A.L.} and Chisholm, {Gary B.} and Michalek, {Joel E.} and Aronow, {Bruce J.} and Barr, {Frederic G.} and R Randall and Marc Ladanyi and Qualman, {Stephen J.} and Rubin, {Brian P.} and LeGaIIo, {Robin D.} and Chiayeng Wang and Javed Khan and Charles Keller",
year = "2009",
month = "4",
day = "1",
doi = "10.1158/0008-5472.CAN-08-3723",
language = "English (US)",
volume = "69",
pages = "2902--2911",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma

AU - Nishijo, Koichi

AU - Chen, Qing Rong

AU - Zhang, Lei

AU - McCleish, Amanda T.

AU - Rodriguez, Andrea

AU - Cho, Min Jung

AU - Prajapati, Suresh I.

AU - Gelfond, Jonathan A.L.

AU - Chisholm, Gary B.

AU - Michalek, Joel E.

AU - Aronow, Bruce J.

AU - Barr, Frederic G.

AU - Randall, R

AU - Ladanyi, Marc

AU - Qualman, Stephen J.

AU - Rubin, Brian P.

AU - LeGaIIo, Robin D.

AU - Wang, Chiayeng

AU - Khan, Javed

AU - Keller, Charles

PY - 2009/4/1

Y1 - 2009/4/1

N2 - The highly aggressive muscle cancer alveolar rhabdomyosar- coma (ABMS) is one of the most common soft tissue sarcoma of childhood, yet the outcome for the unresectable and metastatic disease is dismal and unchanged for nearly three decades. To better understand the pathogenesis of this disease and to facilitate novel preclinical approaches, we previously developed a conditional mouse model of ARMS by faithfully recapitulating the genetic mutations observed in the human disease, i.e., activation of Pax3:Fkhr fusion gene with either p53 or Cdkn2a inactivation. In this report, we show that this model recapitulates the immunohistochemical profile and the rapid progression of the human disease. We show that Pax3:Fkhr expression increases during late preneoplasia but tumor cells undergoing metastasis are under apparent selection for Pax3:Fkhr expression. At a whole-genome level, a cross-species gene set enrichment analysis and metagene projection study showed that our mouse model is most similar to human ARMS when compared with other pediatric cancers. We have defined an expression profile conserved between mouse and human ARMS, as well as a Pax&Fkhr signature, including the target gene, SKP2. We further identified 7 "draggable" kinases overexpressed across species. The data affirm the accuracy of this genetically engineered mouse model.

AB - The highly aggressive muscle cancer alveolar rhabdomyosar- coma (ABMS) is one of the most common soft tissue sarcoma of childhood, yet the outcome for the unresectable and metastatic disease is dismal and unchanged for nearly three decades. To better understand the pathogenesis of this disease and to facilitate novel preclinical approaches, we previously developed a conditional mouse model of ARMS by faithfully recapitulating the genetic mutations observed in the human disease, i.e., activation of Pax3:Fkhr fusion gene with either p53 or Cdkn2a inactivation. In this report, we show that this model recapitulates the immunohistochemical profile and the rapid progression of the human disease. We show that Pax3:Fkhr expression increases during late preneoplasia but tumor cells undergoing metastasis are under apparent selection for Pax3:Fkhr expression. At a whole-genome level, a cross-species gene set enrichment analysis and metagene projection study showed that our mouse model is most similar to human ARMS when compared with other pediatric cancers. We have defined an expression profile conserved between mouse and human ARMS, as well as a Pax&Fkhr signature, including the target gene, SKP2. We further identified 7 "draggable" kinases overexpressed across species. The data affirm the accuracy of this genetically engineered mouse model.

UR - http://www.scopus.com/inward/record.url?scp=66149138870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149138870&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-3723

DO - 10.1158/0008-5472.CAN-08-3723

M3 - Article

C2 - 19339268

AN - SCOPUS:66149138870

VL - 69

SP - 2902

EP - 2911

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -